Careteq is an innovative Australian health technology company dedicated to improving medication management and healthcare safety for aged and at-risk populations. Through its portfolio of brands including HMR Referrals, Sofihub, and Embedded Health Solutions (EHS), the company provides comprehensive technological solutions that enhance clinical outcomes, reduce medication-related risks, and support independent living.
HMR Referrals, one of Careteq’s key offerings, is a Software-as-a-Service (SaaS) platform that connects General Practitioners with Accredited Pharmacists to conduct Home Medication Reviews (HMRs). This service is crucial in addressing medication-related harm, particularly for seniors taking multiple medications. The platform aims to reduce adverse drug reactions, improve medication adherence, and ultimately lower hospitalization rates while creating additional revenue streams for medical clinics.
The company’s technology ecosystem extends beyond medication management, with Sofihub delivering adaptive care technology that enables aged and at-risk individuals to live independently. Through intelligent, proactive solutions, Careteq provides personalized care technologies that offer companionship, instill confidence, and significantly reduce the burden on caregivers. With a strong focus on innovation and patient-centric solutions, Careteq is positioning itself as a leader in transforming healthcare delivery and support for vulnerable populations.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
